Steroid Sensitive Nephrotic Syndrome in Children

Stopped early · Phase 4

Conditions studied: Nephrotic Syndrome in Children

In brief

Idiopathic nephrotic syndrome (INS) is one of the most common glomerular pathologies in children and corticosteroid therapy is its most effective treatment. The total duration of treatment ranges anywhere from two to six months, generally about 3 months. The main objective of our study is to test the feasibility of a shorter total duration (two months) of corticosteroid therapy in patients who show a quicker treatment response to the initial treatment.

Key facts

Study ID

NCT03878914

Run by

Wayne State University

People needed

34

Starts

2019-08-06

Expected to finish

2021-10-31

Last updated by the study team

2022-05-02

Who can join

Age: 1 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 1 to <19 years
• Newly diagnosed INS
• Patient in remission with steroids
• Written informed consent/Assent for the study OR as required by the local IRB

You may not qualify if…

• Age < 1 year or ≥ 19 years
• Uncertainty about patient/parent adherence.
• Abnormal serum creatinine for patient age
• Steroid resistant nephrotic syndrome
• Any co-morbid condition that might require modification in treatment with steroids.

Where it is running

• Wayne Pediatrics — Detroit, Michigan, United States
• Children's Hospital of Fudan University — Shanghai, China

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.